3Borsi JD, Wesenberg F, Stokland T, et al. How much is too much? Folinic acid rescue in children with acute lymphoblastic leukemia. Eur J Cancer,1991, 27:1006-1009.
4Wolfrom C, Hartmann R, Fengler R, et al. Randomized comparison of 36-hour intermediate-dose versus 4-hour high-dose methotrexate infusions for remission induction in relapsed childhood acute lymphoblastic leukemia. J Clin Oncol,1993,11:827-833.
5Henze G, Fengler R, Hartmann R, et al. Six-year experience with a comprehensive approach to the treatment of recurrent childhood acute lymphoblastic leukemia.Blood, 1991,78: 1166-1172.
6Reiter A, Schrappe M, Luwig WD, et al. Successful treatment strategy for Ki-1 anaplastic large-cell lymphoma of childhood: a prospective analysis of 62 patients enrolled in three consecutive Berlin-Frankfurt-Munster group studies. J Clin Oncol ,1994,12:899-908.
8Skarby T, Anderson H, Heldrup J, et ah High teucovorin doses dining high-dose methotrexate treatment may reduce the cure rate in childhood acute lymphoblastic leukemia. Leukemia, 2006, 20 : 1955-1962.
9Odoul F, Le Guellec C, Lamagnere JP, et al. Prediction of methotrexate elimination after high dose infusion in children with acute lymphoblastic leukaemia using a population pharmacokinetic approach. Fundam Clin Pharmacol, 1999, 13: 595-604.
10Seidemann K, Tiemann M, Schrappe M, et al. Short-pulse B-non- Hodgkin lymphoma-type chemotherapy is efficacious treatment for pediatric anaplastic large cell lymphoma: a report of the Berlin- Frankfurt-Munster Group Trial NHL-BFM 90. Blood, 2001, 97: 3699 -3706.
